BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 31612753)

  • 1. Inter-assay variability in automated serum free light chain assays and their use in the clinical laboratory.
    Caponi L; Romiti N; Koni E; Fiore AD; Paolicchi A; Franzini M
    Crit Rev Clin Lab Sci; 2020 Mar; 57(2):73-85. PubMed ID: 31612753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Long-Term Storage on Serum Free Light Chain Stability.
    Hörber S; Klein R; Peter A
    Clin Lab; 2019 May; 65(5):. PubMed ID: 31115238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of free light chains with assays based on monoclonal antibodies.
    Te Velthuis H; Drayson M; Campbell JP
    Clin Chem Lab Med; 2016 Jun; 54(6):1005-14. PubMed ID: 27010775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implication by differential analytical performances of serum free light chain quantitation analysis using fully automated analyzers.
    Yun SY; Rim JH; Park H; Kang H; Lee SG; Lim JB
    Clin Chem Lab Med; 2023 Jun; 61(7):1288-1299. PubMed ID: 37015073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance Evaluation of Serum Free Light Chain Analysis: Nephelometry vs Turbidimetry, Monoclonal vs Polyclonal Reagents.
    Messiaen AS; De Sloovere MMW; Claus PE; Vercammen M; Van Hoovels L; Heylen O; Debrabandere J; Vanpoucke H; De Smet D
    Am J Clin Pathol; 2017 Jun; 147(6):611-622. PubMed ID: 28575180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice.
    Katzmann JA; Abraham RS; Dispenzieri A; Lust JA; Kyle RA
    Clin Chem; 2005 May; 51(5):878-81. PubMed ID: 15774572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a rapid and quantitative lateral flow assay for the simultaneous measurement of serum κ and λ immunoglobulin free light chains (FLC): inception of a new near-patient FLC screening tool.
    Campbell JP; Heaney JL; Shemar M; Baldwin D; Griffin AE; Oldridge E; Goodall M; Afzal Z; Plant T; Cobbold M; Jefferis R; Jacobs JF; Hand C; Drayson MT
    Clin Chem Lab Med; 2017 Mar; 55(3):424-434. PubMed ID: 27505089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Impact of Renal Failure on Correlation and Concordance Between 2 Free Light Chain Assays.
    Moreau C; Autier B; Cavey T; Rouger E; Norwood J; Bendavid C; Escoffre M; Sébillot M; Decaux O
    Clin Lymphoma Myeloma Leuk; 2016 Dec; 16(12):693-704. PubMed ID: 27618362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Free Light Chain Assay: Shift Toward a Higher κ/λ Ratio.
    Rindlisbacher B; Schild C; Egger F; Bacher VU; Pabst T; Leichtle A; Andres M; Sédille-Mostafaie N
    J Appl Lab Med; 2020 Jan; 5(1):114-125. PubMed ID: 32445339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical specificity of two assays for immunoglobulin kappa and lambda free light chains.
    Farnsworth CW; Roemmich B; Spears GM; Murray DL; Dispenzieri A; Willrich MAV
    Clin Chem Lab Med; 2024 Apr; 62(5):929-938. PubMed ID: 38044587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
    Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
    Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain kappa and lambda to polyclonal antibody-based assays and immunofixation electrophoresis.
    Hoedemakers RM; Pruijt JF; Hol S; Teunissen E; Martens H; Stam P; Melsert R; Te Velthuis H
    Clin Chem Lab Med; 2011 Nov; 50(3):489-95. PubMed ID: 22098433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum free light chain analysis: persisting limitations with new kids on the block.
    Van Hoovels L; Vercammen M; Nevejan L; Cornette M; Briers PJ; Deeren D; Van Droogenbroeck J; Fostier K; De Smet D
    Clin Chem Lab Med; 2022 Aug; 60(9):1440-1448. PubMed ID: 35781357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a new free light chain ELISA assay: bringing coherence with electrophoretic methods.
    Jacobs JFM; de Kat Angelino CM; Brouwers HMLM; Croockewit SA; Joosten I; van der Molen RG
    Clin Chem Lab Med; 2018 Jan; 56(2):312-322. PubMed ID: 28771430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Method comparison of three serum free light chain assays on the Roche Cobas 6000 c501 chemistry analyzer.
    Augustijn D; Jacobs JFM; Russcher H
    Clin Chem Lab Med; 2022 Feb; 60(3):379-385. PubMed ID: 34969184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical comparisons of two free light chain assays to immunofixation electrophoresis for detecting monoclonal gammopathy.
    Kim HS; Kim HS; Shin KS; Song W; Kim HJ; Kim HS; Park MJ
    Biomed Res Int; 2014; 2014():647238. PubMed ID: 24971342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.
    Katzmann JA; Clark RJ; Abraham RS; Bryant S; Lymp JF; Bradwell AR; Kyle RA
    Clin Chem; 2002 Sep; 48(9):1437-44. PubMed ID: 12194920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analytical Criticalities Associated to Different Immunological Methods for Serum Free Light Chain Detection in Plasma Cell Dyscrasias: A Description of Particular Clinical Cases.
    Sabatino R; Perrone A; Cuomo M; Liotti S; Barchiesi V; Cantile M; Cavalcanti E
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the analytical performance and the sensitivity of serum free light chains immunoassay in patients with monoclonal gammopathy.
    Wolff F; Thiry C; Willems D
    Clin Biochem; 2007 Mar; 40(5-6):351-4. PubMed ID: 17239359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in kappa to lambda (kappa:lambda) ratios of serum and urinary free light chains.
    Abe M; Goto T; Kosaka M; Wolfenbarger D; Weiss DT; Solomon A
    Clin Exp Immunol; 1998 Feb; 111(2):457-62. PubMed ID: 9486419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.